In March 2025, the company declared new plans for any immediate-to-purchaser offering of its Wegovy weight loss drug. The company proven a different pharmacy, termed NovoCare, which might cost consumers $499 per month for use of the drug, under fifty percent the expense of the drug by other pharmaceutical distribution networks.[fifty three]Novo Nor